.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cipla
Chinese Patent Office
Mallinckrodt
Cantor Fitzgerald
Moodys
Julphar
Express Scripts
Deloitte
McKinsey

Generated: November 20, 2017

DrugPatentWatch Database Preview

Pharmalucence Company Profile

« Back to Dashboard

What is the competitive landscape for PHARMALUCENCE, and what generic and branded alternatives to PHARMALUCENCE drugs are available?

PHARMALUCENCE has fourteen approved drugs.



Summary for Pharmalucence

US Patents:0
Tradenames:14
Ingredients:13
NDAs:14
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmalucence
SELENOMETHIONINE SE 75
selenomethionine se-75
INJECTABLE;INJECTION017322-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmalucence
PYROLITE
technetium tc-99m pyro/trimeta phosphates kit
INJECTABLE;INJECTION017684-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmalucence
SODIUM PERTECHNETATE TC 99M
technetium tc-99m sodium pertechnetate
SOLUTION;INJECTION, ORAL017321-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmalucence
AN-MAA
technetium tc-99m albumin aggregated kit
INJECTABLE;INJECTION017792-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmalucence
TECHNETIUM TC-99M MEBROFENIN
technetium tc-99m mebrofenin kit
INJECTABLE;INJECTION078242-001Jan 29, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmalucence
OSTEOLITE
technetium tc-99m medronate kit
INJECTABLE;INJECTION017972-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmalucence
CIS-MDP
technetium tc-99m medronate kit
INJECTABLE;INJECTION018124-001Approved Prior to Jan 1, 1982APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmalucence
SODIUM PERTECHNETATE TC 99M
technetium tc-99m sodium pertechnetate
SOLUTION;INJECTION, ORAL017321-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmalucence
TECHNETIUM TC 99M SESTAMIBI
technetium tc-99m sestamibi kit
INJECTABLE;INJECTION079157-001Jul 10, 2009APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmalucence
IOBENGUANE SULFATE I 131
iobenguane sulfate i-131
INJECTABLE;INJECTION020084-001Mar 25, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Pharmalucence

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmalucence
IOBENGUANE SULFATE I 131
iobenguane sulfate i-131
INJECTABLE;INJECTION020084-001Mar 25, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
AstraZeneca
Teva
Dow
Julphar
Federal Trade Commission
Citi
Chubb
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot